###begin article-title 0
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes
###end article-title 0
###begin p 1
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 1351 1352 1351 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1479 1483 1479 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
The prevalence of CD36 deficiency in East Asian and African populations suggests that the causal variants are under selection by severe malaria. Previous analysis of data from the International HapMap Project indicated that a CD36 haplotype bearing a nonsense mutation (T1264G; rs3211938) had undergone recent positive selection in the Yoruba of Nigeria. To investigate the global distribution of this putative selection event, we genotyped T1264G in 3420 individuals from 66 populations. We confirmed the high frequency of 1264G in the Yoruba (26%). However, the 1264G allele is less common in other African populations and absent from all non-African populations without recent African admixture. Using long-range linkage disequilibrium, we studied two West African groups in depth. Evidence for recent positive selection at the locus was demonstrable in the Yoruba, although not in Gambians. We screened 70 variants from across CD36 for an association with severe malaria phenotypes, employing a case-control study of 1350 subjects and a family study of 1288 parent-offspring trios. No marker was significantly associated with severe malaria. We focused on T1264G, genotyping 10 922 samples from four African populations. The nonsense allele was not associated with severe malaria (pooled allelic odds ratio 1.0; 95% confidence interval 0.89-1.12; P = 0.98). These results suggest a range of possible explanations including the existence of alternative selection pressures on CD36, co-evolution between host and parasite or confounding caused by allelic heterogeneity of CD36 deficiency.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C1">1</xref>
###xml 249 262 249 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C1">1</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C4">4</xref>
###xml 335 348 335 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C5">5</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C6">6</xref>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C1">1</xref>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C7">7</xref>
###xml 1085 1086 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C8">8</xref>
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 249 262 <span type="species:ncbi:5833">P. falciparum</span>
###xml 335 348 <span type="species:ncbi:5833">P. falciparum</span>
Erythrocytes infected with mature forms of the Plasmodium falciparum parasite adhere to endothelium, platelets, leucocytes and uninfected erythrocytes, a behaviour considered key to the pathogenesis of severe falciparum malaria (1). The majority of P. falciparum clinical isolates bind CD36 (1-4). A family of variant molecules called P. falciparum erythrocyte membrane protein 1 (PfEMP1) is responsible for binding CD36 and other host antigens (5). PfEMP1 is expressed by the parasite onto the surface of infected red blood cells (iRBCs) and is subject to switching during the course of an infection. CD36 is found on a range of cell types including platelets, dendritic cells and endothelium (6). Adhesion of iRBCs to endothelial CD36 helps the parasite avoid splenic passage, contributes to microcirculatory occlusion and promotes local inflammatory responses (1). CD36-mediated binding of iRBCs to dendritic cells inhibits their maturation and function (7), and CD36 on platelets is required for the formation of platelet-mediated clumps, which are associated with severe disease (8).
###end p 3
###begin p 4
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C9">9</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C10">10</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C11">11</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C13">13</xref>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
CD36 deficiency (or Naka-negative blood group) has been reported in Japanese (9), Thais (10) and African-Americans (11). The prevalence of CD36 deficiency in East Asian and African populations raises the possibility that the responsible variants have been selected for by malaria. The molecular basis of CD36 deficiency in African-Americans is distinct from that found in East Asia (12). Common alleles reported in East Asia include a proline to serine missense mutation at codon 90 of the CD36 gene (C478T) and a frameshift mutation at codon 317 (1159insA) (13). The commonest reported African CD36 deficiency allele is a nonsense mutation in exon 10 of CD36 (T1264G; rs3211938), which terminates the polypeptide before the second transmembrane domain (12).
###end p 4
###begin p 5
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C14">14</xref>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 891 893 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C15">15</xref>
###xml 894 896 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C16">16</xref>
Further evidence that evolutionary selection has shaped genetic variation at the CD36 locus emerged from phase 1 of the International Haplotype Map (HapMap) project (14). The HapMap project performed whole-genome high-resolution genotyping in samples from four populations including 30 parent-offspring trios from the Yoruba ethnic group from Ibadan in southwestern Nigeria, 30 parent-offspring trios from Utah (of northern and western European ancestry), 45 unrelated Han Chinese from Beijing and 45 unrelated Japanese from Tokyo. The CD36 nonsense allele, 1264G, was common in the Yoruba (approximately25%) but not detected in other populations. The 1264G allele was present on haplotypes found to be unusually similar over hundreds of kilobases (see ). This signal, termed extended haplotype homozygosity (EHH), suggested that 1264G had been under recent positive evolutionary selection (15,16).
###end p 5
###begin p 6
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP192TB1">1</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C17">17</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C18">18</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C19">19</xref>
###xml 239 247 <span type="species:ncbi:9606">children</span>
###xml 551 559 <span type="species:ncbi:9606">children</span>
###xml 702 710 <span type="species:ncbi:9606">children</span>
###xml 808 816 <span type="species:ncbi:9606">children</span>
###xml 922 930 <span type="species:ncbi:9606">children</span>
Genetic epidemiological studies of severe falciparum malaria have examined whether CD36 deficiency alleles affect susceptibility, but have not produced consistent answers (Table 1). An initial case-control study of 1359 Gambian and Kenyan children found CD36 deficiency appeared to be associated with susceptibility to severe disease, leading the authors to propose that another infectious pathogen was responsible for the frequency of CD36 deficiency in East Asians and Africans (12). In contrast, a matched case-control study of 693 pairs of Kenyan children found that 1264G heterozygotes were protected from malaria, particularly from having multiple syndromes of malaria (17). A third study of 223 children from Ibadan in Nigeria was unable to detect a significant difference in T1264G frequency between children with severe disease and those with asymptomatic parasitaemia (18). However, a recent study of 913 Kenyan children has, once again, suggested that 1264G is associated with susceptibility to malaria (19).
###end p 6
###begin p 7
Published risk estimates of severe malaria phenotypes associated with CD36 deficiency alleles
###end p 7
###begin p 8
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
OR, odds ratio; CI, confidence interval; def, CD36 deficiency alleles 1264G and 1439C pooled; wt, CD36 wild-type allele; the remaining alleles and genotypes refer to CD36 T1264G. CM, cerebral malaria; SA, severe anaemia; Severe, all severe cases; Uncomplicated, non-severe malaria.
###end p 8
###begin p 9
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aMantel-Haenszel stratified analysis.
###end p 9
###begin p 10
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bSample numbers in brackets refer to subsets of the studies' cases or controls.
###end p 10
###begin p 11
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cMultivariate analysis.
###end p 11
###begin p 12
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
dWeighted for population differentiation (Yoruba versus Masai).
###end p 12
###begin p 13
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
eWeighted for population differentiation (Yoruba versus Kikuyu).
###end p 13
###begin p 14
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 118 234 118 234 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">Determine the distribution of the putative T1264G selection event in a range of African and non-African populations.</p>
###xml 118 234 118 234 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="15">Determine the distribution of the putative T1264G selection event in a range of African and non-African populations.</p></list-item>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 234 322 234 322 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="16">Replicate the <italic>CD36</italic> EHH signal in the Yoruba and, if possible, in additional populations.</p>
###xml 234 322 234 322 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="16">Replicate the <italic>CD36</italic> EHH signal in the Yoruba and, if possible, in additional populations.</p></list-item>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 322 671 322 671 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="17">Test single-nucleotide polymorphisms (SNPs) across <italic>CD36</italic> for associations with severe malaria. Previous genetic association studies have focused on T1264G, and only a fraction of variation across the gene has been analysed. Other SNPs in or near <italic>CD36</italic> may demonstrate novel disease associations and could assist the fine-mapping of functional changes.</p>
###xml 322 671 322 671 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="17">Test single-nucleotide polymorphisms (SNPs) across <italic>CD36</italic> for associations with severe malaria. Previous genetic association studies have focused on T1264G, and only a fraction of variation across the gene has been analysed. Other SNPs in or near <italic>CD36</italic> may demonstrate novel disease associations and could assist the fine-mapping of functional changes.</p></list-item>
###xml 671 807 671 807 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="18">Employ a series of population- and family-based studies of severe malaria phenotypes to refine the risk estimate associated with T1264G.</p>
###xml 671 807 671 807 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="18">Employ a series of population- and family-based studies of severe malaria phenotypes to refine the risk estimate associated with T1264G.</p></list-item>
###xml 118 807 118 807 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="roman-lower"><list-item><p textid="15">Determine the distribution of the putative T1264G selection event in a range of African and non-African populations.</p></list-item><list-item><p textid="16">Replicate the <italic>CD36</italic> EHH signal in the Yoruba and, if possible, in additional populations.</p></list-item><list-item><p textid="17">Test single-nucleotide polymorphisms (SNPs) across <italic>CD36</italic> for associations with severe malaria. Previous genetic association studies have focused on T1264G, and only a fraction of variation across the gene has been analysed. Other SNPs in or near <italic>CD36</italic> may demonstrate novel disease associations and could assist the fine-mapping of functional changes.</p></list-item><list-item><p textid="18">Employ a series of population- and family-based studies of severe malaria phenotypes to refine the risk estimate associated with T1264G.</p></list-item></list>
We set out to analyse in detail the relationship between CD36 variation and severe malaria. Our aims were as follows. Determine the distribution of the putative T1264G selection event in a range of African and non-African populations.Replicate the CD36 EHH signal in the Yoruba and, if possible, in additional populations.Test single-nucleotide polymorphisms (SNPs) across CD36 for associations with severe malaria. Previous genetic association studies have focused on T1264G, and only a fraction of variation across the gene has been analysed. Other SNPs in or near CD36 may demonstrate novel disease associations and could assist the fine-mapping of functional changes.Employ a series of population- and family-based studies of severe malaria phenotypes to refine the risk estimate associated with T1264G.
###end p 14
###begin p 15
Determine the distribution of the putative T1264G selection event in a range of African and non-African populations.
###end p 15
###begin p 16
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Replicate the CD36 EHH signal in the Yoruba and, if possible, in additional populations.
###end p 16
###begin p 17
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Test single-nucleotide polymorphisms (SNPs) across CD36 for associations with severe malaria. Previous genetic association studies have focused on T1264G, and only a fraction of variation across the gene has been analysed. Other SNPs in or near CD36 may demonstrate novel disease associations and could assist the fine-mapping of functional changes.
###end p 17
###begin p 18
Employ a series of population- and family-based studies of severe malaria phenotypes to refine the risk estimate associated with T1264G.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
A global survey of CD36 haplotypes and T1264G
###end title 20
###begin p 21
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C18">18</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP192F1">1</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C20">20</xref>
###xml 1585 1587 1585 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C21">21</xref>
###xml 120 125 <span type="species:ncbi:9606">Human</span>
###xml 519 527 <span type="species:ncbi:9606">children</span>
We genotyped the T1264G polymorphism in 3420 individuals from 66 ethnic groups. These included 974 individuals from the Human Genome Diversity Project (HGDP)-Centre d'Etude du Polymorphisme Humain (CEPH) Diversity Panel (51 ethnic groups) and 2446 additional Gambian, Malawian, Kenyan and Ghanaian cord blood samples and population controls (15 ethnic groups). The 1264G allele was at a frequency of 26% in the Yoruba of Nigeria, a finding consistent with the HapMap Yoruba (24.2%) and another recent study of Nigerian children (18). The 1264G allele was present in populations across sub-Saharan Africa, but was generally less frequent than in the Yoruba (Fig. 1). The 1264G allele was not seen in two African populations living in the regions of lower malaria risk, the South African Bantu and the Namibian San. However, their limited sample sizes may mean the allele is present at low frequencies but undetected. The pygmies of central Africa, such as the Biaka (Central African Republic) and the Mbuti (Democratic Republic of Congo), are relatively genetically isolated from other sub-Saharan populations. There is, however, evidence that the Biaka have experienced admixture with neighbouring groups (20). This is consistent with the presence of 1264G alleles in the Biaka (5.8%) but not in the Mbuti (0%). The 1264G allele was absent from almost all non-African ethnic groups. The Makrani of Pakistan were the only group outside of Africa (and the only Pakistani ethnic group) to have 1264G (2.1%). The presence of 1264G is consistent with past African admixture in the Makrani (21). For a full breakdown of samples genotyped and 1264G allele frequencies, see .
###end p 21
###begin p 22
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Frequencies of the CD36 1264G nonsense allele in a range of African and Middle Eastern populations. For each population, the country of origin, number of individuals samples and 1264G allele frequency are given (in parentheses) as follows: 1, Fula, Jola, Mandinka, Manjago, Serehuli, Serere and Wolloff (The Gambia, 582, 2%); 2, Mandenka (Senegal, 21, 0%); 3, Kasem, Nankan and Buli (Ghana, 737, 14%); 4, Yoruba (Nigeria, 25, 26%); 5, Biaka Pygmy (Central African Republic, 26, 5.8%); 6, Mbuti Pygmy (Democratic Republic of Congo, 7, 0%); 7, northeastern Bantu (Kenya, 11, 4.5%); 8, Chonyi, Duruma, Giriama and Kauma (Kenya, 722, 8.6%); 9, Malawians (Malawi, 405, 8.9%); 10, San (Namibia, 6, 0%); 11, southeastern and southwestern Bantu (South Africa, 7, 0%); 12, Mozabite (Mzab region of Algeria, 23, 0%); 13, Palestinian, Druze and Bedouin (Israel, 138, 0%); 14, Sindhi, Pathan, Kalash, Hazara, Burusho, Brahui and Balochi (Pakistan, 158, 0%); 15, Makrani (Pakistan, 24, 2.1%). The 1264G allele is absent from all other populations assayed but not shown in this figure.
###end p 22
###begin p 23
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP192F2">2</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C22">22</xref>
###xml 1593 1595 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C14">14</xref>
###xml 1954 1956 1894 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C15">15</xref>
We genotyped 53 additional SNPs, in and around CD36, in the HGDP-CEPH Diversity Panel. These markers comprised 12 intragenic SNPs (average density 1 SNP/6.3 kb) and 41 SNPs extending 300 kb up- and downstream of CD36 (average density 1 SNP/15.3 kb). We compared haplotypes carrying 1264G with those bearing the ancestral 1264T, calculating the EHH surrounding the core SNP (T1264G) (see Materials and Methods). EHH reflects the probability that two haplotypes, chosen at random from a population, will share identical markers, from the core SNP to a specified test position. Haplotypes carrying the 1264G allele were more similar over longer distances than those with the ancestral T-allele (Fig. 2), a common trend when comparing ancestral and derived alleles (22). Measured approximately100 kb upstream from the core SNP (at rs1851937), the 1264G haplotype EHH was still 1.0 compared with 0.117 for 1264T, while at approximately300 kb upstream (rs304775), 1264G EHH was 0.462 versus 0.026 for 1264T. Downstream, however, EHH values were lower, and there was less difference between the two haplotype subtypes; at approximately100 kb (rs12669309), EHH was 0.231 (G) versus 0.12 (T), and 0.064 (G) versus 0.006 (T) at approximately300 kb (rs2367090). To assess the significance of these differences, we measured relative EHH (REHH, the ratio between EHH on haplotypes marked by 1264G and haplotypes bearing the T-allele) at a distance of approximately0.25 cM from the core SNP and compared these measurements with the empirical genome-wide distribution of the long-range haplotype (LRH) test (14)). The REHH was 17.6 (5') and 3.2 (3'). In other words, the EHH was 17-fold greater on haplotypes bearing 1264G at 0.25 cM upstream. This 5' value is >99th centile compared with the empirical distribution of REHH and similar to (or greater than) previous reports of alleles under selection in Africans [e.g. G6PD deficiency, haplotype frequency 18%, REHH 7 (15)]. However, the 3' REHH of 3.2 was not significant.
###end p 23
###begin p 24
###xml 237 238 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 274 275 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 322 323 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
EHH decay surrounding T1264G in HGDP Yoruba, HapMap Yoruba and Gambian trios. Breakdown of extended haplotype homozygosity (EHH) with distance, on haplotypes partitioned by the alleles of T1264G (rs3211938; the 'core' SNP). We compared (A) 25 HGDP-CEPH Yoruba individuals, (B) HapMap genotypes from 60 Yoruba parents and (C) 202 Gambian parents.
###end p 24
###begin p 25
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP192F2">2</xref>
###xml 579 581 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C14">14</xref>
For comparison, we downloaded phased haplotypes from the HapMap Yoruba, paring down the data set to the same 54 SNPs (including T1264G) (Fig. 2). As expected, EHH measurements were greater on 1264G haplotypes. Upstream EHH was, at approximately100 kb, 0.741 (G) versus 0.089 (T); at approximately300 kb, 0.571 (G) versus 0.012 (T); downstream, at approximately100 kb, 0.483 (G) versus 0.129 (T); and at approximately300 kb, 0.227 (G) versus 0.005 (T). The HapMap Yoruba had REHH values of 29.7 (5') and 14.6 (3') [both >99th centile and consistent with the original observation (14)]. REHH values for our HGDP Yoruba are lower than those for the HapMap Yoruba, particularly downstream of T1264G. There are a range of explanations for these differences: (i) the HapMap data had a slightly lower missing genotype rate (1 versus 3% for HGDP); (ii) the HapMap haplotypes were inferred from higher density marker data; (iii) our HGDP sample size was smaller (50 haplotypes versus 120 HapMap haplotypes); and (iv) the HapMap haplotypes were inferred from parent-offspring trios. Offspring genotypes can be used to unambiguously resolve phase at some parental markers. To test the impact of phasing accuracy on EHH, we obtained Yoruba genotypes from the HapMap project and phased them without utilizing offspring data (treating the parents as 60 unrelated individuals). The resulting haplotypes had an REHH of 29.6 upstream, but only 5.1 downstream (). This suggests that the asymmetry in HGDP Yoruba REHH, between 5' and 3' regions, may reflect technical artefacts affecting haplotype estimation downstream (e.g. assay performance, phasing accuracy) rather than a biological signal (e.g. selection acting on sequences upstream of T1264G).
###end p 25
###begin p 26
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP192F2">2</xref>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Too few 1264G haplotypes were sampled from the Makrani, the Biaka of the Central African Republic or the northeastern Bantu for a valid assessment of EHH to be made. To study 1264G haplotypes in detail, we selected 101 parent-offspring trios from our Gambian family study (see next section). Twenty-six trios were selected because one or both parents had the 1264G allele. The remaining 75 were randomly chosen from the family study. Samples were genotyped and analysed in a manner similar to the HGDP-CEPH Diversity Panel. Offspring genotypes were used to assist phasing. In total, 30 1264G haplotypes were compared with 374 1264T haplotypes (Fig. 2). EHH values on Gambian CD36 1264G haplotypes were raised. Upstream EHH was, at approximately100 kb, 0.405 (G) versus 0.082 (T); at approximately300 kb, 0.184 (G) versus 0.006 (T); downstream, at approximately100 kb, 0.607 (G) versus 0.114 (T); and at approximately300 kb, 0.122 (G) versus 0.003 (T). REHH was 19.1 upstream and 12.8 downstream. However, EHH is often raised around low frequency, derived alleles. The significance of these results was determined using phased genome-wide SNP data from 658 Gambian parent-offspring trios genotyped on an Illumina 650Y BeadArray platform (manuscript in preparation). The offspring in these trios were malaria cases; so to minimize bias, we analysed only untransmitted parental chromosomes. We calculated the REHH for 15 807 derived alleles of frequency 1-3%, where REHH could be assessed at 0.25 +/- 0.01 cM from the core SNP. Comparison with this empirical, genome-wide distribution of the LRH test suggests our Gambian REHH values are not significantly unusual, approximately59th centile (12.8) and approximately77th centile (19.1). This finding highlights that low-frequency alleles are often surrounded by long haplotypes, limiting the power of EHH testing.
###end p 26
###begin title 27
Genetic association studies with severe malaria phenotypes
###end title 27
###begin p 28
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
###xml 761 764 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt;</italic>
###xml 1023 1024 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1086 1087 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1216 1218 1216 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1345 1348 1345 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt;</italic>
###xml 367 375 <span type="species:ncbi:9606">children</span>
Seventy CD36 SNPs, including T1264G and G1439C [a missense mutation in strong linkage disequilibrium in Gambians with the 1444delA frameshift mutation, another CD36 deficiency allele (12)], were tested for disease associations in Gambian case-control and family studies (see Material and Methods for further details of SNP selection). The family study comprised 1288 children affected by severe malaria and both parents [these trios included 508 cases of cerebral malaria (CM) and 333 cases of severe malarial anaemia (SA)]. The case-control study was separate from the family study and comprised 727 cases of severe malaria (339 CM, 226 SA) and 623 population controls. Both studies were powered to detect realistic effect sizes at a significance threshold of P <0.05. Only one marker, rs4728191, an intronic SNP, exceeded this threshold in both studies. The minor allele was associated with protection on both occasions [case-control, severe malaria, allelic odds ratio (OR) 0.76; 95% confidence interval (CI) 0.61-0.96, P = 0.019; family study, SA, allelic OR 0.70; 95% CI 0.5-0.99, P = 0.041]. This finding needs cautious interpretation, as the associations were with different phenotypes and the Hardy-Weinberg P-value for rs4728191 in cord blood controls was marginal (P = 0.006). All results from the case-control and family studies with P <0.05 are documented in .
###end p 28
###begin p 29
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP192F3">3</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt;</italic>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 602 603 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Using the UNPHASED application, we combined the case-control and family data into a single analysis (Fig. 3). Given that 70 SNPs have been tested, the formal significance threshold, with conservative Bonferroni correction, would be roughly 0.0007 (0.05/70). No marker in CD36 had P <0.002 for any genetic model or phenotype. Rs4728191 was not significantly associated with severe malaria phenotypes in the combined analysis (severe malaria, allelic OR 0.89; 95% CI 0.79-1.01, P = 0.06; SA allelic OR 0.84; 95% CI 0.67-1.06, P = 0.13). Neither T1264G (severe malaria, allelic OR 0.93; 95% CI 0.67-1.29, P = 0.65), nor G1439C (severe malaria, allelic OR 0.90; 95% CI 0.68-1.19, P = 0.46), nor both deficiency alleles considered together (severe malaria, allelic OR 0.91; 95% CI 0.73-1.13, P = 0.39) were significantly associated with severe malaria phenotypes. Complete results from the pooled analysis are documented in .
###end p 29
###begin p 30
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
P-values for the pooled Gambian case-control and family studies. Allelic model P-values derived from UNPHASED analysis of 70 SNPs across CD36, for severe falciparum malaria (Severe), and the subphenotypes of cerebral malaria (CM) and severe malarial anaemia (SA). The arrow marks the position of T1264G (rs3211938). Chromosome 7 coordinates from NCBI build 36/dbSNP 126.
###end p 30
###begin p 31
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C17">17</xref>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1087 1140 1087 1140 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32">718 Malawian cases and 405 controls (640 CM, 101 SA);</p>
###xml 1087 1140 1087 1140 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="32">718 Malawian cases and 405 controls (640 CM, 101 SA);</p></list-item>
###xml 1140 1191 1140 1191 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="33">708 Kenyan cases and 902 controls (216 CM, 270 SA);</p>
###xml 1140 1191 1140 1191 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="33">708 Kenyan cases and 902 controls (216 CM, 270 SA);</p></list-item>
###xml 1191 1224 1191 1224 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">225 Malawi trios (216 CM, 39 SA);</p>
###xml 1191 1224 1191 1224 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">225 Malawi trios (216 CM, 39 SA);</p></list-item>
###xml 1224 1257 1224 1257 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">234 Kenyan trios (114 CM, 85 SA);</p>
###xml 1224 1257 1224 1257 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="35">234 Kenyan trios (114 CM, 85 SA);</p></list-item>
###xml 1257 1309 1257 1309 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">792 Ghanaian cases and 806 controls (44 CM, 296 SA).</p>
###xml 1257 1309 1257 1309 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">792 Ghanaian cases and 806 controls (44 CM, 296 SA).</p></list-item>
###xml 1087 1309 1087 1309 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="roman-lower"><list-item><p textid="32">718 Malawian cases and 405 controls (640 CM, 101 SA);</p></list-item><list-item><p textid="33">708 Kenyan cases and 902 controls (216 CM, 270 SA);</p></list-item><list-item><p textid="34">225 Malawi trios (216 CM, 39 SA);</p></list-item><list-item><p textid="35">234 Kenyan trios (114 CM, 85 SA);</p></list-item><list-item><p textid="36">792 Ghanaian cases and 806 controls (44 CM, 296 SA).</p></list-item></list>
Given the previous report of protection associated with 1264G heterozygotes (17), we specifically checked for such an effect. Deficiency allele heterozygotes did tend to be underrepresented among cases (versus wild-type homozygotes, OR 0.83; 95% CI 0.66-1.05). In addition, no CD36-deficient individual (e.g. 1264G homozygote, 1439C homozygote or compound heterozygote) was found among the 727 cord blood controls, although several were seen among the cases (three in the case-control study and eight in the family study) (deficiency allele homozygotes versus wild-type homozygotes OR 1.59; 95% CI 0.74-3.39). Together these results suggested a non-significant trend towards heterozygote advantage (overdominant model P = 0.09). However, the low frequency of 1264G (1.9%) and 1439C (1.8%) in Gambians limited the statistical power. To increase the power, we genotyped T1264G and G1439C in five further sample sets derived from populations where 1264G is more common (8.2% in Kenyan controls, 9.0% in Malawian controls and 14.2% in Ghanaian controls). These additional studies comprised: 718 Malawian cases and 405 controls (640 CM, 101 SA);708 Kenyan cases and 902 controls (216 CM, 270 SA);225 Malawi trios (216 CM, 39 SA);234 Kenyan trios (114 CM, 85 SA);792 Ghanaian cases and 806 controls (44 CM, 296 SA).
###end p 31
###begin p 32
718 Malawian cases and 405 controls (640 CM, 101 SA);
###end p 32
###begin p 33
708 Kenyan cases and 902 controls (216 CM, 270 SA);
###end p 33
###begin p 34
225 Malawi trios (216 CM, 39 SA);
###end p 34
###begin p 35
234 Kenyan trios (114 CM, 85 SA);
###end p 35
###begin p 36
792 Ghanaian cases and 806 controls (44 CM, 296 SA).
###end p 36
###begin p 37
The 1439C allele was at a frequency of 0.1% in Ghanaian controls, but absent in Kenya and Malawi.
###end p 37
###begin p 38
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP192TB2">2</xref>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP192TB3">3</xref>
T1264G was not associated with severe malarial phenotypes in the additional five studies individually. Pooling data across all seven studies (5681 cases and controls, and 1747 nuclear family trios) using the UNPHASED application, we found no association between T1264G (severe malaria, allelic OR 1.0; 95% CI 0.89-1.12, P = 0.98) or deficiency alleles (1264G and 1439C pooled, severe malaria, allelic OR 0.98; 95% CI 0.89-1.09, P = 0.76) and severe malaria (Table 2). The putative trend towards a heterozygous advantage, suggested by the Gambian data, was not supported by this larger data set (deficiency allele heterozygotes versus wild-type homozygotes, OR 0.97; 95% CI 0.86-1.09; deficiency allele homozygotes versus wild-type homozygotes, OR 1.09; 95% CI 0.74-1.6; overdominant model P = 0.53) (Table 3).
###end p 38
###begin p 39
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
Estimated risk for CD36 T1264G in severe malaria
###end p 39
###begin p 40
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
Allelic odds ratios (OR) and 95% confidence intervals (CI) for CD36 1264G compared with the T-allele, in severe malaria. P-values were derived from logistic regression analysis with covariates of ethnic group, gender and HbS genotype (population-based studies), case-pseudo-control analysis (family studies) or UNPHASED analysis (pooled data across all studies).
###end p 40
###begin p 41
Pooled analysis of CD36 deficiency alleles and severe malaria phenotypes
###end p 41
###begin p 42
###xml 497 499 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
Pooled analysis performed from our seven studies using the UNPHASED application. Phenotypes: Severe, severe falciparum malaria; SA, severe malarial anaemia; CM, cerebral malaria. Markers: T1264G or both CD36 deficiency (def) alleles pooled (G1439C + 1444delA and T1264G). T1264G genotypes: GG, 1264G homozygotes; GT, heterozygotes; TT, 1264T homozygotes; het, deficiency allele heterozygotes; hom, deficiency allele homozygotes; wt, wild-type homozygotes; OR, odds ratio; CI, confidence interval; P-values are reported for four genetic models rec(essive), over(dominant), dom(inant) and allelic.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C14">14</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C16">16</xref>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP192TB1">1</xref>
We set out to analyse the distribution of 1264G haplotypes in a range of global populations, to screen variation across the gene for association with severe malaria and to target 1264G with well-powered tests of disease association. It is important to stress that the initial observation of raised EHH on 1264G haplotypes was only briefly noted in previous work, with little discussion of its biological significance (14,16). This study represents the first detailed description of the CD36 EHH signal found in the HapMap Yoruba. In addition, we presented novel data from the HGDP collection exploring the frequency of the nonsense allele across Africa and replicating the EHH signal in the Yoruba. Our association study of severe malaria and T1264G employed a sample size more than twice that of all previous studies combined (Table 1). Given our relative statistical power, the marginal significance of past results and their inconsistent outcomes, our data suggest that CD36 T1264G is not associated with severe malaria. Furthermore, no CD36 marker tested appeared to be significantly associated with disease susceptibility.
###end p 44
###begin p 45
###xml 1545 1558 1545 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1687 1689 1687 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C23">23</xref>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C24">24</xref>
###xml 1733 1735 1733 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C25">25</xref>
###xml 1755 1757 1755 1757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C26">26</xref>
###xml 1774 1776 1774 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C27">27</xref>
###xml 1798 1800 1798 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C28">28</xref>
###xml 1545 1558 <span type="species:ncbi:5833">P. falciparum</span>
The reason for the expansion of the 1264G allele in West-Central Africa is unclear. Nigeria has a high prevalence of malaria infection, however, so does the Gambia (1264G frequency 2%) and costal regions of Kenya (9%). The high frequency in Nigeria might indicate a recent origin for the allele in that region with subsequent migration. The lower allele frequency outside Nigeria could simply reflect selective sweeps in progress, but at earlier stages. There are a range of plausible explanations for the presence of selection in the absence of a malaria association. It is possible that the signal of selection detected around 1264G could be spurious; or that host-parasite co-evolution has eliminated the advantage of this allele, subsequent to an initial selective sweep. Alternatively, the failure to detect an association might represent type II error. The 1264G allele could provide a modest degree of protection from severe malaria (e.g. an OR between 0.95 and 1); protect from an infrequent but life-threatening malaria phenotype; or only offer protection to the rare deficiency allele homozygotes. This association study would have only limited power to detect an effect in these situations. A small effect size might be sufficient to maintain the allele at low frequency in populations. Hypothetically, the expansion of 1264G alleles in the Yoruba could represent a local selection event on top of a low-level background of selection by malaria. The additional Yoruba event could also be malaria-related, for example the effects of a P. falciparum strain specific to southwestern Nigeria. However, CD36 operates in a range of key biological processes including thrombostasis (23), glucose metabolism (24), lipid handling (25), immune function (26), angiogenesis (27) and possibly taste (28). Therefore, other environmental factors need to be considered as selective pressures.
###end p 45
###begin p 46
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 503 505 503 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C19">19</xref>
Combining evidence for natural selection with disease association statistics has been proposed as a technique to increase power to detect disease associations. Our data highlights a potential pitfall for this approach. In recently published work, an association between T1264G and severe malaria (P = 0.03) was combined with the substantial allele frequency difference between the Yoruba (a population exposed to endemic malaria) and the Kikuyu and Masai (populations at low malaria risk). The combined P-values reported were highly significant (up to P = 0.00043) (19). However, as we have seen, there is a substantial T1264G allele frequency difference between the Yoruba and most African populations, including others exposed to endemic malaria. This highlights the possibility that marginal evidence of a genetic association with disease A (e.g. severe malaria) could be conflated with strong evidence of natural selection caused by an unrelated process B (e.g. a novel dietary source). Combined analysis remains an exciting approach, but ensuring a signal of selection relates to the same disease as association data (or gauging the degree of confidence) will be a challenge.
###end p 46
###begin p 47
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C29">29</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C30">30</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C25">25</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C31">31</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C32">32</xref>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 666 668 666 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C33">33</xref>
###xml 861 874 861 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 927 929 927 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1101 1114 1101 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1135 1136 1135 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C1">1</xref>
###xml 1137 1138 1137 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C4">4</xref>
###xml 1213 1221 1213 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1586 1587 1586 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C2">2</xref>
###xml 1588 1589 1588 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C3">3</xref>
###xml 1590 1592 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C34">34</xref>
###xml 1593 1595 1593 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C35">35</xref>
###xml 1701 1702 1701 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C6">6</xref>
###xml 2083 2084 2083 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C1">1</xref>
###xml 2085 2087 2085 2087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C36">36</xref>
###xml 2267 2269 2267 2269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C36">36</xref>
###xml 2270 2272 2270 2272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C37">37</xref>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
###xml 861 874 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1101 1114 <span type="species:ncbi:5833">P. falciparum</span>
It is possible that CD36 deficiency alleles cause deleterious consequences, particularly in the homozygous state, that balance any hypothetical advantages. These include neonatal immune thrombocytopenia (29), altered aerobic exercise capacity (30) and dysregulation of lipid metabolism (25). There is also, ironically, evidence that absence of CD36 is disadvantageous to the host during malaria infection. IRBCs are recognized and phagocytosed by monocytes and macrophages following CD36 binding (31,32). One disease association study based in Thailand (475 adult patients with severe or mild malaria) reported an intronic dinucleotide repeat allele in CD36 [in3(TG)12] associated with protection from severe malaria (33). The authors showed that other alleles of the same microsatellite were associated with the production of a short CD36 isoform altering the P. falciparum-binding epitope. In contrast, the protective in3(TG)12 allele was associated with a full-length transcript, leading the authors to suggest that iRBC binding to intact CD36 could facilitate efficient clearance. The majority of P. falciparum isolates bind CD36 (1-4) yet only a fraction of infections lead to life-threatening consequences. In vitro binding studies suggest that parasite strains from asymptomatic controls with parasitaemia have high levels of CD36 binding, whereas strains from individuals with non-severe, uncomplicated disease have moderate levels of CD36 binding. The lowest levels of CD36 binding are found in isolates from individuals with severe phenotypes such as CM, and particularly SA (2,3,34,35). CD36 (also known as fatty acid translocase) is highly expressed in adipose tissue and skeletal muscle (6). Absence of CD36 as a target for sequestration on these large capillary beds may promote splenic passage and clearance of CD36-binding parasites. This could select for parasite clones which have switched to alternative host ligands. Post-mortem immunohistochemistry studies show relatively low expression of CD36 on brain endothelium without increased expression during malaria (1,36). In contrast, other host ligands of PfEMP1, such as intercellular adhesion molecule-1 and E-selectin, are commonly expressed on cerebral endothelium and induced by inflammation (36,37).
###end p 47
###begin p 48
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C38">38</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C39">39</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C12">12</xref>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C40">40</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C41">41</xref>
###xml 1208 1212 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
CD36 deficiency alleles have been reported to modulate expression in a tissue-specific way. Some variants prevent expression on platelets (CD36 deficiency type II), whereas other alleles abolish CD36 expression on a wider range of cells including platelets, macrophages, monocytes and probably other cell types (type I) (38,39). The 1264G allele is considered to be a type I allele, but little is known about expression patterns (if any) on non-haematopoietic cells. In addition to T1264G and 1444delA, a range of CD36 deficiency alleles have been reported in populations of African origin. These include 990delG and 1530ins14bp (12). Sequencing in Gambians has suggested that 1264G and 1444delA are the commonest deficiency alleles in this population, with others being <1% frequency (12). However, caution is required when extrapolating these findings across Africa. Allelic heterogeneity, particularly when unrecognized, has the potential to impair power in association analysis (40,41) and could also be complicating our population genetic study. The frequency distribution of CD36 deficiency across Africa could be quite different than suggested by typing just 1264G and 1439C+1444delA. Resequencing of CD36 in a range of African and Asian populations is needed to describe the full repertoire and geographic distribution of CD36 deficiency alleles.
###end p 48
###begin p 49
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In conclusion, the relationship between CD36 and malaria is complex. The putative selection event associated with the CD36 1264G nonsense allele appears to be focused in West-Central Africa, although this and other CD36 deficiency alleles are present across sub-Saharan and Asian populations. A number of factors may explain the lack of an association between CD36 variation and severe malaria phenotypes. However, the existence of alternative (or additional) selection pressures on CD36 deficiency alleles is an interesting possibility that needs further investigation. Additional field- and in vitro work is required to define the phenotypic consequences of CD36 deficiency alleles in health and disease.
###end p 49
###begin title 50
MATERIALS AND METHODS
###end title 50
###begin title 51
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Genome Diversity Panel
###end title 51
###begin title 52
Sample preparation and genotyping.
###end title 52
###begin p 53
###xml 103 139 103 139 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.cephb.fr/HGDP-CEPH-Panel/">http://www.cephb.fr/HGDP-CEPH-Panel/</uri>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C42">42</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C43">43</xref>
DNA was derived from lymphoblastoid cell lines of 1064 individuals from the HGDP-CEPH Diversity Panel (http://www.cephb.fr/HGDP-CEPH-Panel/) (42). Samples from 15 known duplicate and atypical individuals were excluded (43). Genotyping was performed using Sequenom iPLEX assays. SNP identifiers, coordinates and genotyping success rates are documented in . Following quality control for missing genotypes, a set of 974 individuals were selected for further analysis (average genotyping success rate 96.7%; rs3211938 success rate 99.8%).
###end p 53
###begin title 54
Statistical analysis.
###end title 54
###begin p 55
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C44">44</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C45">45</xref>
###xml 204 263 204 263 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://ihg2.helmholtz-muenchen.de/cgi-bin/mueller/webehh.pl">http://ihg2.helmholtz-muenchen.de/cgi-bin/mueller/webehh.pl</uri>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C15">15</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C46">46</xref>
Phased haplotypes and missing data were inferred using PHASE (version 2.1) (44,45). Genotype data from each population was phased on its own. EHH calculations were performed using a web-based calculator (http://ihg2.helmholtz-muenchen.de/cgi-bin/mueller/webehh.pl). REHH was assessed as described previously (15,46). REHH was assessed both sides of the core SNP (5' and 3'). The average REHH values for the two markers closest to and either side of 0.25 cM were used for the LRH test [5', rs704871 (0.267 cM) and rs2944398 (0.225 cM); 3', rs10487878 (0.236 cM) and rs4731861 (0.325 cM)].
###end p 55
###begin title 56
Genetic association studies
###end title 56
###begin title 57
Phenotype definition.
###end title 57
###begin p 58
###xml 62 75 62 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C47">47</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C48">48</xref>
###xml 15 23 <span type="species:ncbi:9606">children</span>
###xml 62 75 <span type="species:ncbi:5833">P. falciparum</span>
All cases were children admitted to hospital with evidence of P. falciparum on blood film and clinical features of severe malaria (47,48). We used a Blantyre coma score of </=2 as a criterion of CM (because of the limitations of the available data, we used </=3 in Ghanaian cases) and <5 g/dl or packed cell volume <15% as a criterion of SA. Some individuals had both CM and SA. Of the severe malaria cases that were not CM or SA by these criteria, most had lesser degrees of coma (Blantyre coma score 3) or anaemia (haemoglobin 5-6 g/dl), or other complications such as respiratory distress. In Gambia, Malawi and Kenya, controls were cord blood samples obtained from birth clinics in the same locations as the cases. Ghanaian controls were community controls matched for age, ethnic group and location of origin.
###end p 58
###begin title 59
Subjects.
###end title 59
###begin p 60
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 415 427 <span type="species:ncbi:9606">participants</span>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
Patient samples were collected during ongoing epidemiological studies of severe malaria at the Royal Victoria Hospital, Banjul, The Gambia; the Queen Elizabeth Central Hospital, Blantyre, Malawi; Kilifi District Hospital, Kilifi, Kenya; and Navrongo War Memorial Hospital, Ghana. All DNA samples were collected and genotyped following approval from the relevant research ethics committees and informed consent from participants. See  for demographic details of patients and controls.
###end p 60
###begin title 61
Power calculations.
###end title 61
###begin p 62
###xml 70 111 70 111 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://pngu.mgh.harvard.edu/~purcell/gpc/">http://pngu.mgh.harvard.edu/~purcell/gpc/</uri>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C49">49</xref>
Power calculations were performed using the Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/) (49). For a type I error rate of 0.05, the Gambian case-control and family studies had 85.7 and 98.7% power, respectively. This is based on an allelic OR of 1.3 and a high-risk allele frequency of 0.25 (the average minor allele frequency of the SNPs screened in the Gambians). With lower allele frequencies (0.1, 0.05 and 0.01), the case-control studies (each roughly 700 cases and 700 controls) had lower power, 59.1, 36 and 11.4%, respectively. The additional family studies (approximately 250 trios) each had approximately25.8, 16.0 and 7.2% power. The power of the combined case-control study (2945 cases and 2736 controls) was 99.3, 89.6 and 31.5%. The combined family study (1747 trios) had 93.3, 71.6 and 21.3% power.
###end p 62
###begin title 63
SNP selection.
###end title 63
###begin p 64
###xml 48 69 48 69 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.hapmap.org">http://www.hapmap.org</uri>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C50">50</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C51">51</xref>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 727 728 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
SNP data from HapMap release 21a (January 2007, http://www.hapmap.org) within 10 kb of the CD36 gene was downloaded and assessed using HAPLOVIEW (version 3.32) (50). Polymorphic SNPs (minor allele frequency >5%) were identified in the HapMap Yoruba. Tagging SNPs were defined using the TAGGER algorithm (51). Sequenom iPLEX genotyping assays were designed for 69 tagging SNPs and three additional variants, T1264G, G1439C and rs3173798 (located at a conserved splice site). Following quality control, 70 SNPs were accepted for association analysis. This final set of SNPs tagged 116 of 133 (87%) polymorphic markers (>5% frequency) across CD36 (including 10 kb up- and downstream), using pairwise tagging and an r2 >0.8 (mean r2 = 0.97), in the HapMap Yoruba.
###end p 64
###begin title 65
Sample preparation and genotyping.
###end title 65
###begin p 66
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C52">52</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C53">53</xref>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Genomic DNA samples used in the association analysis underwent whole-genome amplification through either primer extension pre-amplification (52) or multiple displacement amplification (53), before Sequenom iPLEX genotyping. Genotype data underwent quality control for missing data (<10%), Hardy-Weinberg equilibrium (P > 0.001) and Mendelian error rate. Genotype counts and quality control measures are documented in .
###end p 66
###begin title 67
Statistical analysis.
###end title 67
###begin p 68
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C54">54</xref>
###xml 605 653 605 653 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www-gene.cimr.cam.ac.uk/clayton/software/">http://www-gene.cimr.cam.ac.uk/clayton/software/</uri>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C55">55</xref>
###xml 1037 1099 1037 1099 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/">http://www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/</uri>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP192C56">56</xref>
Case-control association analysis was performed by logistic regression using covariates of ethnic group, gender and haemoglobin S (HbS) status. Sequenom genotyping for the HbS variant was performed for all samples as described previously (54). Family-based association analysis was performed using a case-pseudo-control approach and conditional logistic regression based on parental genotypes. Trios were drawn from a larger pool of samples assessed for relationship misspecification by Mendelian error rates. We utilized the R statistical application (version 2.6.0) along with the dgc.genetics library (http://www-gene.cimr.cam.ac.uk/clayton/software/) and the SNPassoc package (55). In both family- and population-based studies, we tested each marker in allelic (or 'multiplicative'), dominant, recessive and overdominant (or 'heterozygote advantage') genetic models and with three phenotypes (CM, SA and all severe cases). Pooling across case-control and family studies was performed using the UNPHASED application (version 3.0.12) (http://www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/) (56). Ethnic origin was a significant confounder and was retained as a covariate in the UNPHASED analysis.
###end p 68
###begin title 69
SUPPLEMENTARY MATERIAL
###end title 69
###begin p 70
.
###end p 70
###begin title 71
[Supplementary Data]
###end title 71
###begin title 72
FUNDING
###end title 72
###begin p 73
###xml 31 45 31 45 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wellcome Trust</funding-source>
###xml 47 58 47 58 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GR074586AIA</award-id>
###xml 122 149 122 149 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UK Medical Research Council</funding-source>
###xml 196 276 196 276 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wellcome Trust, MalariaGEN and the European Union Network 6 BioMalPar Consortium</funding-source>
###xml 343 396 343 396 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institute of Allergy and Infectious Diseases</funding-source>
###xml 397 426 397 426 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 428 451 428 451 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">contract number AI95363</award-id>
This work was supported by the Wellcome Trust (GR074586AIA) through a Clinical Research Training Fellowship to A.E.F. and UK Medical Research Council funding (to D.P.K.). T.N.W. was funded by the Wellcome Trust, MalariaGEN and the European Union Network 6 BioMalPar Consortium. The work of the Ghanaian study was supported by funding from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (contract number AI95363) to the Noguchi Memorial Institute for Medical Research. Funding to pay the Open Access charge was provided by the Wellcome Trust.
###end p 73
###begin title 74
ACKNOWLEDGEMENTS
###end title 74
###begin p 75
We would like to thank the MalariaGEN consortium for providing access to the Illumina 650Y Gambian parent-offspring trio data. This manuscript is published with the permission of the director of the Kenya Medical Research Institute. The views expressed here are the personal ones of the authors and do not purport to represent those of the United States Department of the Navy.
###end p 75
###begin p 76
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 76
###begin title 77
REFERENCES
###end title 77
###begin article-title 78
###xml 65 86 65 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 65 86 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum
###end article-title 78
###begin article-title 79
###xml 41 62 41 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 20 28 <span type="species:ncbi:9606">children</span>
###xml 41 62 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors
###end article-title 79
###begin article-title 80
###xml 33 54 33 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 33 54 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 91 99 <span type="species:ncbi:9606">children</span>
Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria
###end article-title 80
###begin article-title 81
###xml 24 45 24 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 24 45 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions
###end article-title 81
###begin article-title 82
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1
###end article-title 82
###begin article-title 83
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
###end article-title 83
###begin article-title 84
A role for CD36 in the regulation of dendritic cell function
###end article-title 84
###begin article-title 85
###xml 30 51 30 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 30 51 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria
###end article-title 85
###begin article-title 86
A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion
###end article-title 86
###begin article-title 87
###xml 13 18 <span type="species:ncbi:9606">human</span>
Frequency of human platelet antigens among blood donors in northeastern Thailand
###end article-title 87
###begin article-title 88
Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians
###end article-title 88
###begin article-title 89
Malaria susceptibility and CD36 mutation
###end article-title 89
###begin article-title 90
Phenotype-genotype correlation in CD36 deficiency types I and II
###end article-title 90
###begin article-title 91
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 91
###begin article-title 92
###xml 43 48 <span type="species:ncbi:9606">human</span>
Detecting recent positive selection in the human genome from haplotype structure
###end article-title 92
###begin article-title 93
###xml 34 39 <span type="species:ncbi:9606">human</span>
Positive natural selection in the human lineage
###end article-title 93
###begin article-title 94
A non-sense mutation in Cd36 gene is associated with protection from severe malaria
###end article-title 94
###begin article-title 95
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 53 61 <span type="species:ncbi:9606">children</span>
Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria?
###end article-title 95
###begin article-title 96
Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human population genetic structure and inference of group membership
###end article-title 97
###begin article-title 98
Y-chromosomal DNA variation in Pakistan
###end article-title 98
###begin article-title 99
###xml 50 55 <span type="species:ncbi:9606">human</span>
Haplotype homozygosity and derived alleles in the human genome
###end article-title 99
###begin article-title 100
Isolation of the thrombospondin membrane receptor
###end article-title 100
###begin article-title 101
Genetic study of the CD36 gene in a French diabetic population
###end article-title 101
###begin article-title 102
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
###end article-title 102
###begin article-title 103
Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death
###end article-title 103
###begin article-title 104
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
###end article-title 104
###begin article-title 105
CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions
###end article-title 105
###begin article-title 106
Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature
###end article-title 106
###begin article-title 107
Attenuated aerobic exercise capacity in CD36 deficiency
###end article-title 107
###begin article-title 108
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance
###end article-title 108
###begin article-title 109
###xml 99 120 99 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 99 120 <span type="species:ncbi:5833">Plasmodium falciparum</span>
CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum
###end article-title 109
###begin article-title 110
CD36 polymorphism is associated with protection from cerebral malaria
###end article-title 110
###begin article-title 111
###xml 51 72 51 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 51 72 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Receptor-specific adhesion and clinical disease in Plasmodium falciparum
###end article-title 111
###begin article-title 112
###xml 33 54 33 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 33 54 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model
###end article-title 112
###begin article-title 113
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration
###end article-title 113
###begin article-title 114
###xml 87 92 <span type="species:ncbi:9606">human</span>
A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain
###end article-title 114
###begin article-title 115
Molecular basis of CD36 deficiency. Evidence that a 478C->T substitution (proline90->serine) in CD36 cDNA accounts for CD36 deficiency
###end article-title 115
###begin article-title 116
###xml 175 178 <span type="species:ncbi:9606">man</span>
Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man
###end article-title 116
###begin article-title 117
Complexity and power in case-control association studies
###end article-title 117
###begin article-title 118
Effect of allelic heterogeneity on the power of the transmission disequilibrium test
###end article-title 118
###begin article-title 119
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human genome diversity cell line panel
###end article-title 119
###begin article-title 120
###xml 38 43 <span type="species:ncbi:9606">Human</span>
Standardized subsets of the HGDP-CEPH Human Genome Diversity Cell Line Panel, accounting for atypical and duplicated samples and pairs of close relatives
###end article-title 120
###begin article-title 121
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
###end article-title 121
###begin article-title 122
A new statistical method for haplotype reconstruction from population data
###end article-title 122
###begin article-title 123
The case for selection at CCR5-Delta32
###end article-title 123
###begin article-title 124
Severe and complicated malaria
###end article-title 124
###begin article-title 125
###xml 50 58 <span type="species:ncbi:9606">children</span>
Indicators of life-threatening malaria in African children
###end article-title 125
###begin article-title 126
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits
###end article-title 126
###begin article-title 127
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 127
###begin article-title 128
Efficiency and power in genetic association studies
###end article-title 128
###begin article-title 129
Whole genome amplification from a single cell: implications for genetic analysis
###end article-title 129
###begin article-title 130
Multiple displacement amplification as a pre-polymerase chain reaction (pre-PCR) to process difficult to amplify samples and low copy number sequences from natural environments
###end article-title 130
###begin article-title 131
###xml 92 113 92 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 92 113 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria
###end article-title 131
###begin article-title 132
SNPassoc: an R package to perform whole genome association studies
###end article-title 132
###begin article-title 133
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
###end article-title 133

